PAR 4.17% 23.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-11

  1. 2,136 Posts.
    lightbulb Created with Sketch. 798
    The 3.8 quarters is misleading, it’s the equation of current balance by the previous quarterly outflow of $6.8m.
    $26.2m by $6.8m = 3.8
    But as we know the $7.3m RnD refund is not included otherwise our runway would calculate as 1.8 quarters left of cash.
    Current quarter spend estimate is $7m - $10m, let’s go middle ground of $8.5m, that would leave $6.3m for each quarter of the remaining 2.8 quarters.

    Basically what I’m saying is those forward quarterly estimates can be taken with a gain of salt as they are not actual forward cash projections.

    I prefer to just go with the commentary, at the end of this quarter we should have $16m cash worst case if they keep to guidance.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢
Change
-0.010(4.17%)
Mkt cap ! $80.45M
Open High Low Value Volume
24.5¢ 24.5¢ 23.0¢ $179.4K 748.8K

Buyers (Bids)

No. Vol. Price($)
11 90677 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 43446 2
View Market Depth
Last trade - 16.10pm 13/06/2024 (20 minute delay) ?
Last
23.3¢
  Change
-0.010 ( 3.13 %)
Open High Low Volume
24.5¢ 24.5¢ 23.0¢ 157998
Last updated 15.59pm 13/06/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.